Yarbrough Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,221
Closed -$831K 195
2024
Q3
$831K Hold
13,221
0.03% 100
2024
Q2
$781K Hold
13,221
0.03% 100
2024
Q1
$1.05M Hold
13,221
0.05% 90
2023
Q4
$1.04M Hold
13,221
0.05% 92
2023
Q3
$923K Hold
13,221
0.05% 95
2023
Q2
$914K Sell
13,221
-2,908
-18% -$207K 0.05% 96
2023
Q1
$1.2M Hold
16,129
0.1% 85
2022
Q4
$1.5M Hold
16,129
0.12% 73
2022
Q3
$1.54M Hold
16,129
0.12% 72
2022
Q2
$1.5M Hold
16,129
0.11% 72
2022
Q1
$1.63M Hold
16,129
0.09% 83
2021
Q4
$1.66M Buy
+16,129
New +$1.49M 0.09% 94

Other funds holding CVS

Yarbrough Capital's CVS Position: Q4 2024 in Review

Yarbrough Capital sold out of CVS Health (CVS) in Q4 2024, closing a stake of 13,221 shares — an estimated $831K sold.

Yarbrough Capital first reported a position in CVS in Q4 2021 and held it in 12 quarters. The position peaked at $1.66M in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Yarbrough Capital reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Yarbrough Capital sold 13,221 CVS Health shares in Q4 2024, an estimated $831K.
  • Yarbrough Capital first reported a position in CVS Health in Q4 2021 and held it in 12 quarters.
  • Yarbrough Capital's CVS Health position peaked at $1.66M in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Yarbrough Capital's 13F filing for Q4 2024, filed 15 Jan 2025.